Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation’s Phase I Clinical Trial for the Treatment of Parkinson’s Disease

IRVINE, Calif., May 23, 2016 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Company”), the world’s leading cryogenic logistics company for the life sciences industry, today announced that it will provide global logistics support to International Stem Cell Corporation’s (OTCQB: ISCO) (“ISCO”) for its Phase I clinical trial in Australia for the treatment of moderate to severe […]

Read More >>